125 related articles for article (PubMed ID: 11797118)
1. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.
Aoyama Y; Yamane T; Hino M; Ohta K; Nakamae H; Yamamura R; Koh KR; Takubo T; Inoue T; Tatsumi Y; Tatsumi N
Ann Hematol; 2001 Dec; 80(12):752-4. PubMed ID: 11797118
[TBL] [Abstract][Full Text] [Related]
2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
4. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
5. [Aggressive NK cell leukemia/lymphoma: an autopsy case].
Takai K; Sanada M
Rinsho Ketsueki; 2001 Aug; 42(8):621-6. PubMed ID: 11579501
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
7. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
8. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
[TBL] [Abstract][Full Text] [Related]
9. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
10. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
[TBL] [Abstract][Full Text] [Related]
11. [Aggressive natural killer cell lymphoproliferative disease of large granular lymphocytes with leukemia-like clinical course in the terminalstage].
Tsukada T; Ohno T; Morita K; Otsuji H; Sekine T; Nishikawa M; Kobayashi T; Kita K; Shirakawa S; Namba K
Rinsho Ketsueki; 1991 Feb; 32(2):162-6. PubMed ID: 2027242
[TBL] [Abstract][Full Text] [Related]
12. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.
Matsuo Y; Drexler HG; Takeuchi M; Tanaka M; Orita K
Leuk Res; 2002 Sep; 26(9):873-9. PubMed ID: 12127564
[TBL] [Abstract][Full Text] [Related]
13. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
14. First reported cases of intravascular large cell lymphoma of the NK cell type: clinical, histologic, immunophenotypic, and molecular features.
Wu H; Said JW; Ames ED; Chen C; McWhorter V; Chen P; Ghali V; Pinkus GS
Am J Clin Pathol; 2005 Apr; 123(4):603-11. PubMed ID: 15743739
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor.
Lau LG; Tan LK; Koay ES; Ee MH; Tan SH; Liu TC
Am J Hematol; 2004 Oct; 77(2):156-60. PubMed ID: 15389907
[TBL] [Abstract][Full Text] [Related]
16. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
Zhang K; Prichard JW; Brown RE
Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
[TBL] [Abstract][Full Text] [Related]
17. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
[TBL] [Abstract][Full Text] [Related]
18. [Reversed C.P.C.: Aggressive NK-cell leukemia/lymphoma].
Koyama T
Rinsho Byori; 2001 Mar; Suppl 115():140-3. PubMed ID: 11391932
[TBL] [Abstract][Full Text] [Related]
19. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
[TBL] [Abstract][Full Text] [Related]
20. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
